Lithium promotes malignant transformation of nontumorigenic cells in vitro.

Afghanistan Drinking water Lithium Oncogenesis Progression Transformation

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
20 Nov 2020
Historique:
received: 25 03 2020
revised: 11 06 2020
accepted: 07 07 2020
pubmed: 30 7 2020
medline: 17 9 2020
entrez: 30 7 2020
Statut: ppublish

Résumé

Because of the deficiency of water caused by the regional disparities of rainfall due to global warming, attention has been given to the use of well water as drinking water in developing countries. Our fieldwork study in Afghanistan showed that there was a maximum value of 3371 μg/L and an average value of 233 μg/L of lithium in well drinking water. Since the level of lithium in well water is higher than the levels in other countries, we investigated the health risk of lithium. After confirming no influence of ≤1000 μM lithium on cell viability, we found that lithium at concentrations of 100 and 500 μM promoted anchorage-independent growth of human immortalized keratinocytes (HaCaT) and lung epithelial cells (BEAS-2B) but not that of human keratinocytic carcinoma cells (HSC-5) or lung epithelial carcinoma cells (A549). The same concentrations of lithium also promoted phosphorylation of c-SRC and MEK/ERK but not that of AKT in the keratinocytes. Inhibitors of c-SRC (PP2) and MEK (PD98059) suppressed the lithium-induced increase in anchorage-independent growth of the keratinocytes. Our results suggested that lithium promoted transformation of nontumorigenic cells rather than progression of tumorigenic cells with preferential activation of the c-SRC/MEK/ERK pathway. Since previous pharmacokinetics studies indicated that it is possible for the serum level of lithium to reach 100 μM by drinking 2.5 L of water containing 3371 μg/L of lithium per day, the high level of lithium contamination in well drinking water in Kabul might be a potential oncogenic risk in humans.

Identifiants

pubmed: 32721671
pii: S0048-9697(20)34354-0
doi: 10.1016/j.scitotenv.2020.140830
pii:
doi:

Substances chimiques

Lithium 9FN79X2M3F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140830

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Makoto Sudo (M)

Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kazunori Hashimoto (K)

Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Voluntary Body, International Health Care in Universities, Nagoya, Japan.

Masafumi Yoshinaga (M)

Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Mohammad Daud Azimi (MD)

Department of Human Resources, Ministry of Public Health, Kabul, Afghanistan.

Said Hafizullah Fayaz (SH)

Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Administrative Office of the President, Deputy Public Relations and Outreach, Kabul, Afghanistan.

Nobuyuki Hamajima (N)

Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Lisa Kondo-Ida (L)

Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Molecular and Cancer Medicine, Faculty of Pharmacy, Meijo University, Nagoya, Japan.

Kiyoshi Yanagisawa (K)

Department of Molecular and Cancer Medicine, Faculty of Pharmacy, Meijo University, Nagoya, Japan.

Masashi Kato (M)

Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Voluntary Body, International Health Care in Universities, Nagoya, Japan; Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi, Japan. Electronic address: katomsasa@med.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH